A detailed history of Gamma Investing LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Gamma Investing LLC holds 423 shares of IMCR stock, worth $11,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares
423
Previous 158 167.72%
Holding current value
$11,953
Previous $5.36 Million 145.9%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$30.06 - $41.49 $7,965 - $10,994
265 Added 167.72%
423 $13.2 Million
Q2 2024

Jul 02, 2024

BUY
$33.78 - $63.75 $743 - $1,402
22 Added 16.18%
158 $5.36 Million
Q1 2024

Apr 05, 2024

BUY
$60.14 - $75.36 $5,833 - $7,309
97 Added 248.72%
136 $8.84 Million
Q4 2023

Feb 01, 2024

BUY
$42.85 - $69.5 $1,671 - $2,710
39 New
39 $2.82 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.